SINGLERA GENOMICS INC.

In News

Non-invasive early detection of cancer four years before conventional diagnosis using a blood test - Nature

Nature - Jul 21, 2020

Singlera Genomics unveils results of ColonES study demonstrating detection of advanced adenoma and colorectal cancer - PR Newswire Canada

PR Newswire Canada - Oct 18, 2018

PDACatch an FDA Breakthrough Device for Pancreatic Cancer Detection - Clinical Lab Products

Clinical Lab Products - May 08, 2023

FinancialContent - Multi Cancer Early Detection Market and Forecast Report 2025-2033, with Profiles of GRAIL, Guardant Health, Illumina, Freenome, Burning Rock Biotech, AnchorDx, Genecast, Singlera Genomics, and More - ResearchAndMarkets.com - FinancialContent

FinancialContent - Aug 21, 2025

Lilly backs Singlera for $20M assault on U.S. assay market - Fierce Pharma

Fierce Pharma - Aug 23, 2016

Genetic Diagnostics Firm Singlera Nets $152.6 Million in Series B Round - Caixin Global

Caixin Global - Dec 16, 2020

10 Chinese Genomics Companies Decoding China - Nanalyze

Nanalyze - Nov 27, 2017

Singlera Genomics and Fudan University unveil results showing Pan-Cancer Early Detection in the Taizhou Longitudinal Study - PR Newswire Canada

PR Newswire Canada - Oct 18, 2018

Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients - Nature

Nature - Feb 07, 2020

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment